跳至主要内容
临床试验/NCT01541358
NCT01541358终止不适用

Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

Stanford University2 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
2
试验地点
2
主要终点
Total Number of Lesions Identified by F-18 NaF PET/CT in Patients With Suspected Skeletal Malignancy

研究概览

简要总结

This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone cancer

详细描述

The objective of the study is to use 18F sodium fluoride (fluorine F-18 sodium fluoride) PET/CT scanning to detect and characterize lesions in patients who have suspected skeletal malignancy. We hypothesize that scanning with 18F-NaF (fluorine F-18 sodium fluoride) is more sensitive for skeletal abnormalities and may better characterize lesions than conventional imaging.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients referred for evaluation of suspected skeletal cancer
  • Patients must understand and voluntarily sign an informed consent form after the contents have been fully explained to them

排除标准

  • Patients who cannot complete a PET/CT scan
  • Pregnant women
  • Healthy volunteers

结局指标

主要结局

Total Number of Lesions Identified by F-18 NaF PET/CT in Patients With Suspected Skeletal Malignancy

时间窗: an estimated average of 2 hours

F-18 NaF is a positron emission tomography (PET) bone imaging agent that targets changes in the bone. The fluoride ions are taken up in areas of the bone that have increased bone remodeling (bone repair) and increased blood flow, which is indicative of diseases such as cancer.

次要结局

  • Specificity of F-18 NaF PET/CT to Detect Bone Lesions in Patients With Suspected Skeletal Malignancy(an estimated average of 2 hours)
  • Sensitivity of F-18 NaF PET/CT to Detect Bone Lesions in Patients With Suspected Skeletal Malignancy(an estimated average of 2 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrew Quon

Associate Professor of Radiology

Stanford University

研究点 (2)

Loading locations...

相似试验